DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
insulin
New Study Reveals Personalization is Key to Diabetes Management
New study led by Livongo demonstrates that personalization is key to diabetes management and short periods of intensive coaching when people get stuck on their way to their glucose and weight goals can be helpful. A new study reveals that use of Livongo for Diabetes significantly improves the health of people with type 2 diabetes (T2D), according to recent findings reported in the Journal of Diabetes Research. Researchers also found pairing participation in Livongo for Diabetes with lifestyle
Read More
OpenEMR Security Vulnerability Could Expose Medical Records Impacting 90M Patients
Editor's Note: Sven Krewitt is the Senior Vulnerability Researcher for Risk Based Security, a detailed information and analysis on data breaches and vulnerability intelligence. Krewitt brings 11 years of experience as a security specialist and vulnerability researcher. He has previously worked as a Senior Security Specialist focusing on vulnerability analysis, quality assurance, and training of new employees.The first known medical vulnerability currently on record is from June 1985 and was in a
Read More
